Description
• রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন
Indications:
LINATAB M is indicated for:
-
Treatment of type 2 diabetes mellitus
-
Improving glycemic control when diet, exercise, and monotherapy are insufficient
Pharmacology:
-
Metformin: Decreases hepatic glucose production and increases insulin sensitivity.
-
Linagliptin: A DPP-4 inhibitor that enhances incretin hormone levels, increasing insulin release and decreasing glucagon secretion.
Dosage & Administration:
-
Typically, one tablet taken once or twice daily with meals.
-
Dosage adjusted based on patient response and tolerance.
Interaction:
-
Possible interactions with other antidiabetics, ACE inhibitors, diuretics.
-
Caution with drugs affecting renal function.
Contraindications:
-
Hypersensitivity to Metformin or Linagliptin
-
Severe renal impairment
-
Diabetic ketoacidosis
Side Effects:
-
Gastrointestinal symptoms (nausea, diarrhea)
-
Hypoglycemia (especially with other antidiabetics)
-
Rare: pancreatitis, hypersensitivity reactions
Pregnancy & Lactation:
Use only if clearly needed and under medical supervision.
Precautions & Warnings:
-
Monitor blood glucose and renal function regularly
-
Educate patients about hypoglycemia symptoms
-
Adjust dose in renal impairment
Therapeutic Class:
Oral hypoglycemic agents (Biguanide + DPP-4 inhibitor)
Storage Conditions:
Store below 30°C in a dry place, protected from moisture and light. Keep out of reach of children.
.jpg)
 400MG.jpg)
.jpeg)
.jpeg)
.jpg)
.jpg)
.webp)
.jpg)
.jpg)
.jpeg)
.webp)
.png)
.jpg)
.webp)
.jpeg)
 100 IU 3 ML.webp)
.jpg)
.jpg)
Change Language